Evofem Biosciences Submits Application For Approval Of New Birth Control Method To FDA
Recently, Evofem Biosciences, a clinical biopharmaceutical company dedicated to developing and commercializing innovative technology for women’s sexual and reproductive health, has announced that it has applied for approval from the U.S. Food and Drug Administration for Amphora, which is a Multipurpose Vaginal pH Regulator (MVP-R) for the prevention of pregnancy. Currently, there are a number…